Chemours reports sales of $1.3 billion in the fourth quarter
Wilmington, DE – Chemours reported fourth quarter and full year 2025 earnings, closing the year with record performance in Thermal & Specialized Solutions (TSS) driven by continued adoption of Opteon™ Refrigerants, while setting 2026 guidance calling for earnings growth and improved free cash flow conversion despite ongoing cyclical pressure in Titanium Technologies (TT) and Advanced Performance Materials (APM).
For the fourth quarter, Chemours reported net sales of $1.3 billion, slightly down compared to the corresponding prior-year quarter, with results shaped by a strong TSS performance offset by softer demand and lower cost absorption in TT and APM as the company prioritized cash generation.
For the full year, net sales totaled $5.8 billion, flat year over year, with TSS delivering record annual sales and Opteon™ Refrigerants growing 56%, reflecting continued regulatory driven transitions under the U.S. AIM Act.
Key points:
TSS net sales increased 14% in Q4, led by 37% year over year growth in Opteon™ Refrigerants
Adjusted EBITDA totaled $128 million in Q4 and $742 million for the full year, with lower absorption in TT and APM partially offset by pricing and volume strength in TSS
Free cash flow reached $92 million in Q4, with 72% conversion, and improved more than $1 billion year over year
Chemours established 2026 guidance calling for 3–5% net sales growth, $800–$900 million in adjusted EBITDA, and free cash flow conversion above 25%
In January, the company announced the sale of its former Kuan Yin TiO₂ site, expected to generate approximately $300 million in net proceeds, supporting debt reduction and balance sheet improvement
Chemours’ CEO Denise Dignam reports, “Our fourth quarter results delivered robust cash flow and met our revenue expectations, highlighted by continued momentum in Opteon™ Refrigerants and a record year for TSS. While short term cyclical headwinds in APM impacted results, we prioritized cash generation, which drove strong free cash flow in the quarter.
Although macroeconomic conditions remain tepid, our TiO₂ pricing actions are beginning to take effect, and we remain focused on executing our Pathway to Thrive strategy. The sale of our Kuan Yin TiO₂ site and increased organic cash flow in 2026 will support improved capital allocation and progress toward our long term net leverage target.”
The full earnings release and supplemental materials are available on Chemours’ investor website